Atlas Trials

Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin

Clinical trial NCT02049060 · COMPLETED

Trial details

NCT number
NCT02049060
Sponsor
Armando Santoro, MD
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malignant Pleural MesotheliomaNonsquamous Nonsmall Cell Neoplasm of Lung
Start date
2013-01-01
Primary completion
2016-05-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.